Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Drug development and reprofiling company Sosei (Tokyo, Japan) is raising 11.2 billion Yen ($104 million) in an IPO
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury